{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T09:59:56Z","timestamp":1781258396642,"version":"3.54.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008678","name":"Universit\u00e4t Leipzig","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008678","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Tuberous sclerosis complex (TSC) is a rare genetic neurocutaneous disorder resulting from mutations in the\n                      <jats:italic>TSC1<\/jats:italic>\n                      or\n                      <jats:italic>TSC2<\/jats:italic>\n                      genes, characterized by overgrowth and lesions in multiple organs. While renal angiomyolipomas are commonly seen, lipomas located elsewhere are rarely reported in these patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We identified a heterozygous\n                      <jats:italic>TSC1<\/jats:italic>\n                      mutation in a pediatric patient, who developed a lipoma in the gluteal region, which recurred after surgical resection. We observed a loss of heterozygosity in the lipoma tissue, resulting in TSC1 deficiency and subsequent activation of the mechanistic target of rapamycin (mTOR) signaling pathway. Further in vitro experiments showed that silencing\n                      <jats:italic>TSC1<\/jats:italic>\n                      in adipocyte progenitors led to increased cell proliferation, supporting the hypothesis that\n                      <jats:italic>TSC1<\/jats:italic>\n                      deficiency contributes to lipoma formation. Treatment with mTOR inhibitors, such as sirolimus and torin-1, as well as the phosphoinositide 3-kinase (PI3K) inhibitor alpelisib reduced cell proliferation and pathway activation in\n                      <jats:italic>TSC1<\/jats:italic>\n                      -deficient cells.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study highlights the need for further investigation into the efficacy of pathway inhibitors in managing TSC-related lipomas in vivo and offers a potential treatment avenue for patients suffering from recurrent lipomatosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-026-04442-y","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T07:14:56Z","timestamp":1781248496000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["In vitro study of TSC1 deficiency in preadipocytes: insights into development and treatment options for tuberous sclerosis related lipomatosis"],"prefix":"10.1186","volume":"21","author":[{"given":"Julika E.","family":"Friedrich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Hentschel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandy","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henriette","family":"Kiep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Ar\u00e9lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Platzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Merkenschlager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wieland","family":"Kiess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffi","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami Abou","family":"Jamra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana Le","family":"Duc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antje","family":"Garten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3554-1902","authenticated-orcid":false,"given":"Anna S.","family":"Kirstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"4442_CR1","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.pediatrneurol.2021.07.011","volume":"123","author":"H Northrup","year":"2021","unstructured":"Northrup H, Aronow ME, Bebin EM, Bissler J, Darling TN, Vries PJ. Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations. Pediatr Neurol. 2021;123:50\u201366.","journal-title":"Pediatr Neurol"},{"issue":"12","key":"4442_CR2","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1093\/hmg\/6.12.2155","volume":"6","author":"AC Jones","year":"1997","unstructured":"Jones AC, Daniells CE, Snell RG, Tachataki M, Idziaszczyk SA, Krawczak M, et al. Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis. Hum Mol Genet. 1997;6(12):2155\u201361.","journal-title":"Hum Mol Genet"},{"issue":"11","key":"4442_CR3","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1001\/archderm.1986.01660230090018","volume":"122","author":"JA Klein","year":"1986","unstructured":"Klein JA. Diffuse Lipomatosis and Tuberous Sclerosis. Arch Dermatol. 1986;122(11):1298.","journal-title":"Arch Dermatol"},{"issue":"9","key":"4442_CR4","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/S0300-2896(15)30377-X","volume":"34","author":"JD Alc\u00e1zar","year":"1998","unstructured":"Alc\u00e1zar JD, Ramos R, Verdugo J. Lipomatosis difusa dorsal transtor\u00e1cica en un paciente con esclerosis tuberosa familiar. Arch Bronconeumol. 1998;34(9):468\u20139.","journal-title":"Arch Bronconeumol"},{"issue":"1","key":"4442_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4103\/idoj.IDOJ_60_17","volume":"9","author":"A Mittal","year":"2018","unstructured":"Mittal A, Vinay K, De D, Handa S, Sinha A. Tuberous Sclerosis Complex and Diffuse Lipomatosis: Case Report of a Rare Association. Indian Dermatol Online J. 2018;9(1):37\u20139.","journal-title":"Indian Dermatol Online J"},{"key":"4442_CR6","doi-asserted-by":"publisher","first-page":"2329048X2110480","DOI":"10.1177\/2329048X211048065","volume":"8","author":"M Ilyas","year":"2021","unstructured":"Ilyas M, Quezada J, Opfer EK. Lipomatous Infiltration in Tuberous Sclerosis Complex - A Case Series and Literature Review. Child Neurol Open. 2021;8:2329048X211048065.","journal-title":"Child Neurol Open"},{"issue":"12","key":"4442_CR7","first-page":"e32663","volume":"14","author":"E Pinto","year":"2022","unstructured":"Pinto E, Veiga M, Sagarribay A, Concei\u00e7\u00e3o C. Periodontoid Pseudotumor in Tuberous Sclerosis Associated With Neck Diffuse Lipomatosis. Cureus. 2022;14(12):e32663.","journal-title":"Cureus"},{"issue":"2","key":"4442_CR8","doi-asserted-by":"publisher","first-page":"100968","DOI":"10.1016\/j.jbc.2021.100968","volume":"297","author":"AS Kirstein","year":"2021","unstructured":"Kirstein AS, Kehr S, Nebe M, Hanschkow M, Barth LAG, Lorenz J, et al. PTEN regulates adipose progenitor cell growth, differentiation, and replicative aging. J Biol Chem. 2021;297(2):100968.","journal-title":"J Biol Chem"},{"key":"4442_CR9","doi-asserted-by":"crossref","unstructured":"Kirstein AS, Augustin A, Penke M, Cea M, K\u00f6rner A, Kiess W, et al. The Novel Phosphatidylinositol-3-Kinase (PI3K) Inhibitor Alpelisib Effectively Inhibits Growth of PTEN-Haploinsufficient Lipoma Cells. Cancers (Basel). 2019;11(10):1511.","DOI":"10.3390\/cancers11101586"},{"issue":"4","key":"4442_CR10","doi-asserted-by":"publisher","first-page":"e1004873","DOI":"10.1371\/journal.pcbi.1004873","volume":"12","author":"E Talevich","year":"2016","unstructured":"Talevich E, Shain AH, Botton T, Bastian BC, CNVkit. Genome-Wide Copy Number Detection and Visualization from Targeted DNA Sequencing. PLoS Comput Biol. 2016;12(4):e1004873.","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"4442_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/sj.ijo.0801520","volume":"25","author":"M Wabitsch","year":"2001","unstructured":"Wabitsch M, Brenner RE, Melzner I, Braun M, M\u00f6ller P, Heinze E, et al. Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation. Int J Obes Relat Metab Disord. 2001;25(1):8\u201315.","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"7","key":"4442_CR12","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9(7):676\u201382.","journal-title":"Nat Methods"},{"issue":"1","key":"4442_CR13","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1080\/21623945.2020.1785083","volume":"9","author":"F K\u00e4ssner","year":"2020","unstructured":"K\u00e4ssner F, Kirstein A, H\u00e4ndel N, Schmid GL, Landgraf K, Berthold A, et al. A new human adipocyte model with PTEN haploinsufficiency. Adipocyte. 2020;9(1):290\u2013301.","journal-title":"Adipocyte"},{"issue":"1","key":"4442_CR14","doi-asserted-by":"publisher","first-page":"6589","DOI":"10.1038\/s41598-020-62759-5","volume":"10","author":"ME Reyna-Fabi\u00e1n","year":"2020","unstructured":"Reyna-Fabi\u00e1n ME, Hern\u00e1ndez-Mart\u00ednez NL, Alc\u00e1ntara-Ortigoza MA, Ayala-Sumuano JT, Enr\u00edquez-Flores S, Vel\u00e1zquez-Arag\u00f3n JA, et al. First comprehensive TSC1\/TSC2 mutational analysis in Mexican patients with Tuberous Sclerosis Complex reveals numerous novel pathogenic variants. Sci Rep. 2020;10(1):6589.","journal-title":"Sci Rep"},{"issue":"4","key":"4442_CR15","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/pr.2013.246","volume":"75","author":"GL Schmid","year":"2014","unstructured":"Schmid GL, K\u00e4ssner F, Uhlig HH, K\u00f6rner A, Kratzsch J, H\u00e4ndel N, et al. Sirolimus treatment of severe PTEN hamartoma tumor syndrome: case report and in vitro studies. Pediatr Res. 2014;75(4):527\u201334.","journal-title":"Pediatr Res"},{"key":"4442_CR16","doi-asserted-by":"crossref","unstructured":"Barth LAG, Nebe M, Kalwa H, Velluva A, Kehr S, Kolbig F, et al. Phospholipid Scramblase 4 (PLSCR4) Regulates Adipocyte Differentiation via PIP3-Mediated AKT Activation. Int J Mol Sci. 2022;23(17):9787.","DOI":"10.3390\/ijms23179787"},{"issue":"7711","key":"4442_CR17","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41586-018-0217-9","volume":"558","author":"Q Venot","year":"2018","unstructured":"Venot Q, Blanc T, Rabia SH, Berteloot L, Ladraa S, Duong J-P, et al. Targeted therapy in patients with PIK3CA-related overgrowth syndrome. Nature. 2018;558(7711):540\u20136.","journal-title":"Nature"},{"issue":"4","key":"4442_CR18","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1128\/MCB.00601-09","volume":"30","author":"L-A Julien","year":"2010","unstructured":"Julien L-A, Carriere A, Moreau J, Roux PP. mTORC1-activated S6K1 phosphorylates Rictor on threonine 1135 and regulates mTORC2 signaling. Mol Cell Biol. 2010;30(4):908\u201321.","journal-title":"Mol Cell Biol"},{"issue":"12","key":"4442_CR19","doi-asserted-by":"publisher","first-page":"6262","DOI":"10.1074\/jbc.M115.672170","volume":"291","author":"NM Walker","year":"2016","unstructured":"Walker NM, Belloli EA, Stuckey L, Chan KM, Lin J, Lynch W, et al. Mechanistic Target of Rapamycin Complex 1 (mTORC1) and mTORC2 as Key Signaling Intermediates in Mesenchymal Cell Activation. J Biol Chem. 2016;291(12):6262\u201371.","journal-title":"J Biol Chem"},{"issue":"12","key":"4442_CR20","doi-asserted-by":"publisher","first-page":"4104","DOI":"10.1128\/MCB.00289-08","volume":"28","author":"J Huang","year":"2008","unstructured":"Huang J, Dibble CC, Matsuzaki M, Manning BD. The TSC1-TSC2 complex is required for proper activation of mTOR complex 2. Mol Cell Biol. 2008;28(12):4104\u201315.","journal-title":"Mol Cell Biol"},{"issue":"9","key":"4442_CR21","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1097\/JTO.0000000000000250","volume":"9","author":"S Umemura","year":"2014","unstructured":"Umemura S, Mimaki S, Makinoshima H, Tada S, Ishii G, Ohmatsu H, et al. Therapeutic priority of the PI3K\/AKT\/mTOR pathway in small cell lung cancers as revealed by a comprehensive genomic analysis. J Thorac Oncol. 2014;9(9):1324\u201331.","journal-title":"J Thorac Oncol"},{"key":"4442_CR22","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/1476-4598-10-90","volume":"10","author":"D Roulin","year":"2011","unstructured":"Roulin D, Waselle L, Dormond-Meuwly A, Dufour M, Demartines N, Dormond O. Targeting renal cell carcinoma with NVP-BEZ235, a dual PI3K\/mTOR inhibitor, in combination with sorafenib. Mol Cancer. 2011;10:90.","journal-title":"Mol Cancer"},{"issue":"12","key":"4442_CR23","doi-asserted-by":"publisher","first-page":"4071","DOI":"10.1158\/1078-0432.CCR-11-0445","volume":"17","author":"DM Davies","year":"2011","unstructured":"Davies DM, de Vries PJ, Johnson SR, McCartney DL, Cox JA, Serra AL, et al. Sirolimus therapy for angiomyolipoma in tuberous sclerosis and sporadic lymphangioleiomyomatosis: a phase 2 trial. Clin Cancer Res. 2011;17(12):4071\u201381.","journal-title":"Clin Cancer Res"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-026-04442-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04442-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04442-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T09:15:06Z","timestamp":1781255706000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-026-04442-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4442"],"URL":"https:\/\/doi.org\/10.1186\/s13023-026-04442-y","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"28 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study adhered to the Declaration of Helsinki and all procedures were approved and monitored by the Ethics Committee of Leipzig University, Germany (565\u2009\u2212\u200920\/ek). We confirm that all research was performed in accordance with relevant guidelines and regulations and informed consent was obtained from all participants and\/or their legal guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of their clinical details and clinical images was obtained from the legal guardians of the patient. A copy of the consent form is available for review by the Editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"216"}}